Member Info for Vanilla

Fantastic news wasn't expecting it until end of October so very pleased. Don't forget there are a significant amount of 25p warrants to be absorbed but once these are out of the way this is worth significantly more. We should now look forwards to a raft of positive news regarding further progress towards accreditation and new contracts. As the order book starts filling up I would imagine some big players will start looking closely as this really is disruptive technology that will shake up this market.

Very level advice Wyn that will require discipline to apply. Having bought in here over 2yrs ago with little research my simple plan was to achieve 100% and reached that milestone very quickly. However having carried out more post acquisition research realised this was going to go ballistic once the nailed on lft deals were inked so held on to see 200% gain in just a few months...this is easy. Bit more research and discovered the therapeutics side of the business is going to be even bigger can't believe my luck. Few months later 200% gain turned to a 50% loss oh dear but by this time the therapeutics was motoring ahead and have since returned to a position of profit.
With discipline could of had a good 100% profit, if wasn't greedy could of got out with 200% gain. Having been completely sold on the potential of PreCision I have no idea what or when I will get out of these as the story may just get better and better.......or fall of a cliff but I'm staying to see how it ends.....or might be tempted at £5 or why not £10 no selling some at £3 final!

It's not that at all they're just in a very difficult position in that being completely transparent with timescales is not good for the market. Unfortunately the consequence of these apparent delays is reputational damage and very frustrated share holders. Hopefully all this will be forgotten when they complete before the end of October and potential customers will have the confidence to sign contracts for future orders which shouldn't be too difficult to secure with such a compelling commercial and technological advantage.

Thanks BB and appreciate the reply did wonder whether you asked the question and on that basis they have missed another timescale and my BST expectation is overly generous.
Still doesn't change the investment potential really but only further erodes the BoD's credibility and is why I believe when they achieve a working validated machine a takeover is a serious consideration.

I agree summer is over but the term was used to be as vague and ambiguous as possible with the 31st October being the end of BST always one interpretation. If they miss this date there is always the Southern Hemisphere time difference to fall back on.
It's a shame Billy Bunter didn't put the summer question to them at the agm. Still find it strange no one asked what avo's definition of summer time is.
It's quite clear they don't exactly know and are trying to minimise the damage of giving an achievable date that is too far out. Whilst I was hopeful of an earlier date my expectation was set for the 31st October being end of BST and I really hope they don't disappoint on this as all PI's in this share especially loyal lth's will be deserving of positive news.

Yes and unfortunately Avo BoD are notoriously bad at hitting any timescale. Some here including myself have been waiting over 6 years since the last big 'switch on' event. Very frustrating but just have to accept it's very close and potentially could be very rewarding when it finally works at 230MeV.

That is correct Open but the 4.28 price on the 16th Sept is GBX so although the heading states AUD for some reason the prices shown are sterling pennies so 4.28p to 15.6p which is 265%. Mind you 15.6AUD is £9.20 so maybe we are both wrong!

And those figures are GBX as in pennies sterling not AUD as forecast which is a bit confusing. So not too far away from 20p that many here including myself see as a medium term achievable sp. No doubt AIM will have a completely different opinion but at some point the value of what the company is achieving will be reflected in the sp. Hopefully the statement on the 29th will be very upbeat to start the ball rolling.

From the pre-close trading update:

The Company's results for the year ended 30 June 2022 are expected to be released on 29 September 2022.

If it is the 29th we should get an idea of how Q1 of the current financial year is going.

Haven't you heard the news.....avacta delisted overnight, renamed as Good Therapeutics paid off all existing shareholders and privatised then sold out to roche. I take it that this is not a serious suggestion.

I don't think profitability was forecast until this current financial year starting 1st July 22 to 30th June 23, therefore assume you mean February 23 figures for the half year to end December 22. Those figures should confirm editda positive and becoming cashflow positive in the2nd half.
Hopefully on the 29th we get a current trading statement as part of last years results which indicates all is on track.

23rd of September it is then, only 3 weeks, let's hope they don't spoil the great summer we've had.

Not sure what number it comes under but if you mean current trading for this year 22/23 it's expected to become ebit positive & turning cash positive in the 2nd half of the year.
I'm expecting indications that all is on track to achieve this. As for last years results ending June 22 hopefully they're at least inline with forecasts and provide confidence of achieving the predicted profitable numbers for this financial year.
I'm expecting good news but the sp however who knows, that is down to the mysterious workings of aim.

Cpx seem to have got themselves boxed in to the prizmatic market for IoT which in itself could become substantial. They were always looking for partners to develop the products that the likes of Skeleton, Maxwell & Ioxus seem to have gained market dominance with. Hopefully they will achieve some significant sales with the rebadged Ioxus products but it leaves a slightly confusing view of their status as a developer of supercapacitors.
It seems unlikely they will produce their own products for this market soon unless the tie-up with Ionic will address this so ultimately as they grow the IoT side of the business the only other way to expand into these markets will be through mergers & acquisitions. Ioxus or XS Power Batteries would seem an obvious candidate but the value of cpx will come down to the worth of its prizmatic business and IP which isn't holding back Skeleton so long term how valuable it is will be up for debate.
I think good progress with the current business can get this to 20p but a strategic shift such as this Siemens agreement will be required to get to the next level. I'm not sure how Ionic fits into all of this maybe they will surprise but it does look like the whole supercapacitor market is going to transform and become much bigger which will be good for cpx.

Regarding the discussion on biopsy data in this thread AS did say they would have this as part of the data package. He also mentioned that if a patient left the trial due to becoming too unwell or sadly having deceased then they have left the trial and biopsy data would not be applicable from those patients. Unless I've misunderstood I believe this possibly indicates that they are in possession of biopsy data from patients that will continue to the end of phase 1a.

Looks like a lot sold today just because of the extended trial date. I can understand some people buying in on the strong prospect of a near term postive outcome to the court case.
The real driver here though has got to be becoming profitable on the back of the business from the murata lines producing world leading products for a rapidly growing IoT market. Then there are all the other products I'm sure lth's here are fully aware of the potential and will hopefully soon be rewarded irrespective of the Maxwell case which was always a bonus and certainly not fundamental to the success cpx are now achieving. As mentioned September results will provide the news on progress that matters.

Here's the notes from the case a default judgment was made prior to a trial which was due in the December of the same year. For some reason ioxus just gave up, lost the case then sold out to xs batteries.
I don't see this happening with maxwell so if no deal is agreed it will drag on. I'm sure we'd all prefer an out of court settlement just to put this to bed and get the sp moving up to where it should be. Even a small damages award combined with protecting the IP would be a better outcome than months and months of uncertainty.

ORDER granting [85] Motion for Default Judgment in favor of Cap-XX, Ltd. against Ioxus, Inc. The Court: a. finding that Defendant is liable for infringing the patents-in-suit; b. awarding Plaintiff compensatory damages in the amount of $1,237,717.37 based on a reasonable royalty under 35 U.S.C. ? 284; c. awarding Plaintiff enhanced damages in the amount of $3,713,152.11 based on the trebling of Plaintiffs actual damages under 35 U.S.C. ? 284 for Defendant's willful infringement; d. finding that this case is "exceptional" and award Plaintiff its attorney fees under 35 U.S.C. ? 285; e. granting Plaintiff leave to submit a motion for attorney fees under Rule 54(d)(2) of the Federal Rules of Civil Procedure within fourteen (14) days of the Court's Entry of Default Judgment. (CASE CLOSED) Signed by Judge Colm F. Connolly on 8/5/2020.

You might be right there Mer XS Power Batteries acquired all their assets therefore Ioxus no longer existed for cpx to chase payment. Maybe there was a perception that the takeover was as a result of financial difficulties. I seemed to recall Ioxus not being in a position to continue fighting the case therefore a judgement was made prior to any court hearing. Anyway it was a surprise when the distribution agreement was announced out of the blue, let's hope of similar unexpected news with maxwell!

Yes we need a good update in September so that the move towards profitability becomes the main focus for sp growth and this court case becomes background noise with little interference.
Thinking back to Ioxus I believe they went bankrupt before the case ended thereby paving the way for a judges ruling to close the case and awarding in cpx's favour. There appears no sign of Maxwell conceding so as Open says with the option to appeal this could drag on for a long time.
The legal funding now seems a smart move and the only real winners here may end up being the lawyers but who knows. The sooner the shackles are removed the better and as we understand from the business updates progress is going really well so let's hope the numbers prove this to be the case.

Me too first purchase May 2015 at 3.95p and many more since not a single sell which with hindsight would of been very profitable. The Murata deal has completely transformed this company in my opinion at a time when IoT applications are gaining momentum and the Ioxus deal has provided the range of products that used to be promised with signed MoU's and all the other potential deals that never materialised.
The company is in the position if not better than it should of been years ago just need the SP to catch up and adjust to this new level. All this even without the Maxwell Court case success & if that happens it could release a very tightly coiled spring.